{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:28:08Z","timestamp":1789597688994,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.transci.2011.06.017","type":"journal-article","created":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T21:25:17Z","timestamp":1311888317000},"page":"21-24","source":"Crossref","is-referenced-by-count":12,"title":["The investigation of platelet transfusion refractory in 69 malignant patients undergoing hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"45","author":[{"given":"Guining","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2011.06.017_b0005","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting post transfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.06.017_b0010","unstructured":"American Association of Blood Banks: Technical Manual, 16th ed. Bethesda, MD: American Association of Blood Banks; 2008."},{"key":"10.1016\/j.transci.2011.06.017_b0015","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2011.06.017_b0020","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","article-title":"Platelet transfusion refractoriness","volume":"142","author":"Hod","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2011.06.017_b0085","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V96.3.1150","article-title":"Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect","volume":"96","author":"Mielcarek","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.06.017_b0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1703621","article-title":"Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Stussi","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2011.06.017_b0035","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1016\/j.transproceed.2009.06.189","article-title":"Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation","volume":"41","author":"Ozkurt","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transci.2011.06.017_b0040","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1537-2995.2003.00465.x","article-title":"ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation","volume":"43","author":"Worel","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2011.06.017_b0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.1987.tb02344.x","article-title":"Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions","volume":"67","author":"Murphy","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2011.06.017_b0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V66.5.1105.1105","article-title":"Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement","volume":"66","author":"Hanson","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.06.017_b0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1537-2995.1999.39299154733.x","article-title":"ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation","volume":"39","author":"Benjamin","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2011.06.017_b0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/bbmt.2002.v8.pm12434952","article-title":"A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000\/\u03bcL versus 20, 000\/\u03bcL trigger","volume":"8","author":"Zumberg","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2011.06.017_b0065","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1537-2995.2005.04157.x","article-title":"A prospective randomized trial of a prophylactic platelet transfusion trigger of 10\u00d7109 per L versus 30\u00d7109 per L in allogeneic hematopoietic progenitor cell transplant recipients","volume":"45","author":"Diedrich","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2011.06.017_b0070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bbmt.2007.01.084","article-title":"Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation","volume":"13","author":"Remberger","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2011.06.017_b0075","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.tp.0000167758.63247.f4","article-title":"Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children","volume":"80","author":"Lapierre","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2011.06.017_b0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.seminhematol.2005.05.017","article-title":"Immune hemolysis associated with transplantation","volume":"42","author":"Petz","year":"2005","journal-title":"Semin Hematol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211001042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211001042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T20:57:02Z","timestamp":1592773022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050211001042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1473050211001042"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2011.06.017","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}